None listed
Conditions
Interventions
Drug : Basic monitoring (NIBP, HR, pulse oximetry, bispectral index) after the patient entering the operating theater. After induction of anesthesia with propofol 3-6 ?g/ml, remifentanil 2-6 ng/ml, a
s spontaneous breathing returned, extubation was performed and the patient was transferred to therecovery room. Blood is collected 30 minutes afterstaying in the recovery room (T2).
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients undergoing VATS lobectomy with lung cancer stage 1
Exclusion criteria
Exclusion criteria: • Patients who have not signed consent form • Patients who have heart disease such as myocardial infarction or coronary artery disease other than diabetes, hypertension • Patients with pulmonary disease such as asthma or chronic obstructive pulmonary disease (COPD) • Patients with liver disease or with AST/ALT that is more than twice the normal value • Patients with a history of hypersensitivity to inhaled anesthetics or propofol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| interferon-gamma, IL-4 | — |
Secondary
| Measure | Time frame |
|---|---|
| interferon-gamma/ IL-4 | — |
Countries
Korea, Republic of
Contacts
Public ContactJin Joo
The Catholic University of Korea, Seoul St. Mary's Hospital
Outcome results
None listed